Postoperative long term chemotherapy for advanced gastric cancer

Jpn J Surg. 1976 Jun;6(2):54-9. doi: 10.1007/BF02468887.

Abstract

A postoperative long term chemotherapy was carried out against stage IV gastric cancer with Mitomycin-C, Futraful and a plant polysaccharide, PS-K. The 2-year survival rate was 15 per cent in patients who received an intraoperative Mitomycin-C alone, while it increased to 34 per cent in those receiving the anticancer agents for a prolonged period. The postoperative long term chemotherapy is assumed to be an effective means of improving the therapeutical results of gastric cancer.

MeSH terms

  • Humans
  • Long-Term Care
  • Mitomycins / therapeutic use
  • Polysaccharides / therapeutic use
  • Postoperative Care
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / mortality
  • Tegafur / therapeutic use

Substances

  • Mitomycins
  • Polysaccharides
  • Tegafur